Skip to content
10-Q

Quarterly Report

Cantabio Pharmaceuticals Inc.

0001654954-18-001710

← back to feed
Filed
Feb 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Feb 16, 2018 36.36M sh
Operating Cash Flow Q3 2018 · Dec 31, 2017 −$436K
Operating Cash Flow Q3 2018 · Dec 31, 2016 −$629.75K
Stockholders Equity Q3 2018 · Dec 31, 2017 −$1.8M
Stockholders Equity Q3 2018 · Mar 31, 2017 −$853.92K
Current Liabilities Q3 2018 · Dec 31, 2017 $1.83M
Current Liabilities Q3 2018 · Mar 31, 2017 $887.45K
Total Liabilities Q3 2018 · Dec 31, 2017 $1.83M
Total Liabilities Q3 2018 · Mar 31, 2017 $887.45K
Current Assets Q3 2018 · Dec 31, 2017 $26.77K
Current Assets Q3 2018 · Mar 31, 2017 $33.52K
Total Assets Q3 2018 · Dec 31, 2017 $26.77K
Total Assets Q3 2018 · Mar 31, 2017 $33.52K
Cash And Equivalents Q3 2018 · Dec 31, 2016 $10.8K
Cash And Equivalents Q3 2018 · Mar 31, 2016 $52.11K
Sga Expense Q3 2018 · Dec 31, 2016 $136.93K
Sga Expense Q3 2018 · Dec 31, 2016 $506.68K
Rd Expense Q3 2018 · Dec 31, 2016 $86.87K
Rd Expense Q3 2018 · Dec 31, 2016 $268.67K
Net Income Q3 2018 · Dec 31, 2016 −$227.31K
Net Income Q3 2018 · Dec 31, 2016 −$786.72K